Biography:
PhD. Fang studied drug development at the Inha University, South Korea and got PhD in 2017. And he joined the research group of Prof. Hong at the department of new drug development, Inha University. Recently, we are focusing on developing novel therapeutic strategies including tumor microenvironment and precision medicine, phytochemical agents, receptor tyrosine kinase (RTK) inhibitors, and antibody for treating various malignancies.
A novel combinational therapeutics to overcome chemoresistance in head and neck cancer